US 10865400
PH20 polypeptide variants, formulations and uses thereof
granted A61KA61K38/00A61K38/28
Quick answer
US patent 10865400 (PH20 polypeptide variants, formulations and uses thereof) held by HALOZYME, INC. expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- HALOZYME, INC.
- Grant date
- Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K38/00, A61K38/28, A61K38/47, A61K45/06